Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.
Cytocom has raised $75.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2021.
Cytocom's investors include Avenue Capital Group, Adit Ventures, The Global Emerging Markets Group.
Cytocom is headquartered in Fort Collins, United States.
Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.
Cytocom is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cytocom — Funding & Investors." VCBacked, July 29, 2021, https://www.vcbacked.co/company/cytocom. Accessed August 14, 2026.
VCBacked. (2021). Cytocom — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cytocom
{{cite web |title=Cytocom — Funding & Investors |url=https://www.vcbacked.co/company/cytocom |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated